STABLE TRANSDERMAL PHARMACEUTICAL DRUG DELIVERY SYSTEM COMPRISING RIVASTIGMINE
The present invention relates to a stable transdermal pharmaceutical drug delivery system of rivastigmine or a pharmaceutically acceptable salt thereof, which is free from an antioxidant. In particularly, the present invention relates to a stable transdermal pharmaceutical drug delivery system of ri...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SAPRE, ABHAY SADASHIV DEWANGAN, ASHOK SOLANKI, AMIT KUMAR |
| description | The present invention relates to a stable transdermal pharmaceutical drug delivery system of rivastigmine or a pharmaceutically acceptable salt thereof, which is free from an antioxidant. In particularly, the present invention relates to a stable transdermal pharmaceutical drug delivery system of rivastigmine or a pharmaceutically acceptable salt thereof, which provides an enhanced absorption of drug through skin, and remains stable during a longer storage period. In addition, the present invention relates to a method of treatment of mild to moderate dementia of alzheimer's type and mild to moderate dementia of parkinson's type diseases.
La présente invention concerne un système d'administration de médicament pharmaceutique transdermique stable de rivastigmine ou d'un sel pharmaceutiquement acceptable de celle-ci, qui est exempt d'antioxydant. En particulier, la présente invention concerne un système d'administration de médicament pharmaceutique transdermique stable de rivastigmine ou d'un sel pharmaceutiquement acceptable de celle-ci, qui confère une absorption améliorée de médicament à travers la peau et reste stable pendant une plus longue période de stockage. De plus, la présente invention concerne un procédé de traitement de démence légère à modérée du type Alzheimer et de démence légère à modérée de maladies du type Parkinson. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2014111790A3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2014111790A3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2014111790A33</originalsourceid><addsrcrecordid>eNrjZPALDnF08nFVCAly9At2cQ3ydfRRCPBwBNLOrqEhns5ArktQqLuCi6uPZ5hrUKRCcGRwiKuvgrO_b0CQZ7Cnn7tCkGeYY3CIp7uvp58rDwNrWmJOcSovlOZmUHZzDXH20E0tyI9PLS5ITE7NSy2JD_c3MjA0MTQ0NLc0cDQ2Jk4VABkKMAA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>STABLE TRANSDERMAL PHARMACEUTICAL DRUG DELIVERY SYSTEM COMPRISING RIVASTIGMINE</title><source>esp@cenet</source><creator>SAPRE, ABHAY SADASHIV ; DEWANGAN, ASHOK ; SOLANKI, AMIT KUMAR</creator><creatorcontrib>SAPRE, ABHAY SADASHIV ; DEWANGAN, ASHOK ; SOLANKI, AMIT KUMAR</creatorcontrib><description>The present invention relates to a stable transdermal pharmaceutical drug delivery system of rivastigmine or a pharmaceutically acceptable salt thereof, which is free from an antioxidant. In particularly, the present invention relates to a stable transdermal pharmaceutical drug delivery system of rivastigmine or a pharmaceutically acceptable salt thereof, which provides an enhanced absorption of drug through skin, and remains stable during a longer storage period. In addition, the present invention relates to a method of treatment of mild to moderate dementia of alzheimer's type and mild to moderate dementia of parkinson's type diseases.
La présente invention concerne un système d'administration de médicament pharmaceutique transdermique stable de rivastigmine ou d'un sel pharmaceutiquement acceptable de celle-ci, qui est exempt d'antioxydant. En particulier, la présente invention concerne un système d'administration de médicament pharmaceutique transdermique stable de rivastigmine ou d'un sel pharmaceutiquement acceptable de celle-ci, qui confère une absorption améliorée de médicament à travers la peau et reste stable pendant une plus longue période de stockage. De plus, la présente invention concerne un procédé de traitement de démence légère à modérée du type Alzheimer et de démence légère à modérée de maladies du type Parkinson.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20141023&DB=EPODOC&CC=WO&NR=2014111790A3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20141023&DB=EPODOC&CC=WO&NR=2014111790A3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SAPRE, ABHAY SADASHIV</creatorcontrib><creatorcontrib>DEWANGAN, ASHOK</creatorcontrib><creatorcontrib>SOLANKI, AMIT KUMAR</creatorcontrib><title>STABLE TRANSDERMAL PHARMACEUTICAL DRUG DELIVERY SYSTEM COMPRISING RIVASTIGMINE</title><description>The present invention relates to a stable transdermal pharmaceutical drug delivery system of rivastigmine or a pharmaceutically acceptable salt thereof, which is free from an antioxidant. In particularly, the present invention relates to a stable transdermal pharmaceutical drug delivery system of rivastigmine or a pharmaceutically acceptable salt thereof, which provides an enhanced absorption of drug through skin, and remains stable during a longer storage period. In addition, the present invention relates to a method of treatment of mild to moderate dementia of alzheimer's type and mild to moderate dementia of parkinson's type diseases.
La présente invention concerne un système d'administration de médicament pharmaceutique transdermique stable de rivastigmine ou d'un sel pharmaceutiquement acceptable de celle-ci, qui est exempt d'antioxydant. En particulier, la présente invention concerne un système d'administration de médicament pharmaceutique transdermique stable de rivastigmine ou d'un sel pharmaceutiquement acceptable de celle-ci, qui confère une absorption améliorée de médicament à travers la peau et reste stable pendant une plus longue période de stockage. De plus, la présente invention concerne un procédé de traitement de démence légère à modérée du type Alzheimer et de démence légère à modérée de maladies du type Parkinson.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPALDnF08nFVCAly9At2cQ3ydfRRCPBwBNLOrqEhns5ArktQqLuCi6uPZ5hrUKRCcGRwiKuvgrO_b0CQZ7Cnn7tCkGeYY3CIp7uvp58rDwNrWmJOcSovlOZmUHZzDXH20E0tyI9PLS5ITE7NSy2JD_c3MjA0MTQ0NLc0cDQ2Jk4VABkKMAA</recordid><startdate>20141023</startdate><enddate>20141023</enddate><creator>SAPRE, ABHAY SADASHIV</creator><creator>DEWANGAN, ASHOK</creator><creator>SOLANKI, AMIT KUMAR</creator><scope>EVB</scope></search><sort><creationdate>20141023</creationdate><title>STABLE TRANSDERMAL PHARMACEUTICAL DRUG DELIVERY SYSTEM COMPRISING RIVASTIGMINE</title><author>SAPRE, ABHAY SADASHIV ; DEWANGAN, ASHOK ; SOLANKI, AMIT KUMAR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2014111790A33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2014</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>SAPRE, ABHAY SADASHIV</creatorcontrib><creatorcontrib>DEWANGAN, ASHOK</creatorcontrib><creatorcontrib>SOLANKI, AMIT KUMAR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SAPRE, ABHAY SADASHIV</au><au>DEWANGAN, ASHOK</au><au>SOLANKI, AMIT KUMAR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>STABLE TRANSDERMAL PHARMACEUTICAL DRUG DELIVERY SYSTEM COMPRISING RIVASTIGMINE</title><date>2014-10-23</date><risdate>2014</risdate><abstract>The present invention relates to a stable transdermal pharmaceutical drug delivery system of rivastigmine or a pharmaceutically acceptable salt thereof, which is free from an antioxidant. In particularly, the present invention relates to a stable transdermal pharmaceutical drug delivery system of rivastigmine or a pharmaceutically acceptable salt thereof, which provides an enhanced absorption of drug through skin, and remains stable during a longer storage period. In addition, the present invention relates to a method of treatment of mild to moderate dementia of alzheimer's type and mild to moderate dementia of parkinson's type diseases.
La présente invention concerne un système d'administration de médicament pharmaceutique transdermique stable de rivastigmine ou d'un sel pharmaceutiquement acceptable de celle-ci, qui est exempt d'antioxydant. En particulier, la présente invention concerne un système d'administration de médicament pharmaceutique transdermique stable de rivastigmine ou d'un sel pharmaceutiquement acceptable de celle-ci, qui confère une absorption améliorée de médicament à travers la peau et reste stable pendant une plus longue période de stockage. De plus, la présente invention concerne un procédé de traitement de démence légère à modérée du type Alzheimer et de démence légère à modérée de maladies du type Parkinson.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2014111790A3 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | STABLE TRANSDERMAL PHARMACEUTICAL DRUG DELIVERY SYSTEM COMPRISING RIVASTIGMINE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T14%3A38%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SAPRE,%20ABHAY%20SADASHIV&rft.date=2014-10-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2014111790A3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |